Authors: Cosman, D Mullberg, J Sutherland, CL Chin, W Armitage, R Fanslow, W Kubin, M Chalupny, NJ

Citation: D. Cosman et al., ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor, IMMUNITY, 14(2), 2001, pp. 123-133

Authors: Kubin, M Cassiano, L Chalupny, J Chin, W Cosman, D Fanslow, W Mullberg, J Rousseau, AM Ulrich, D Armitage, R

Citation: M. Kubin et al., ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells, EUR J IMMUN, 31(5), 2001, pp. 1428-1437

Authors: Ghamande, S Hylander, BL Oflazoglu, E Lele, S Fanslow, W Repasky, EA

Citation: S. Ghamande et al., Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin, CANCER RES, 61(20), 2001, pp. 7556-7562

Authors: Borges, L Miller, RE Jones, J Ariail, K Whitmore, J Fanslow, W Lynch, DH

Citation: L. Borges et al., Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand inthe induction of dendritic cells and generation of antitumor immunity in vivo, J IMMUNOL, 163(3), 1999, pp. 1289-1297